Literature DB >> 22775996

The G60S Cx43 mutant enhances keratinocyte proliferation and differentiation.

Jared M Churko1, John J Kelly, Andrew Macdonald, Jack Lee, Jacinda Sampson, Donglin Bai, Dale W Laird.   

Abstract

Transient knock-down of the gap junction protein Cx43 by antisense and siRNA, or gap junction block with mimetic peptides, have been shown to enhance epidermal wound healing. However, patients with oculodentodigital dysplasia (ODDD) express mutant Cx43 that leads to a chronic reduction in gap junctional intercellular communication. To determine whether mutant Cx43 in keratinocytes would impact upon the wound healing process, we localized Cx43 in human and mouse skin tissue expressing mutant Cx43 and assessed the ability of primary keratinocytes derived from a mouse model of ODDD to proliferate, migrate and differentiate. In the epidermis from an ODDD patient and in the epidermis of mice expressing the G60S mutant or in keratinocytes obtained from mutant mice, Cx43 was frequently found within intracellular compartments and rarely localized to punctate sites of cell-cell apposition. Primary keratinocytes derived from G60S mutant mice proliferated faster but migrated similarly to keratinocytes derived from wild-type control mice. Keratinocytes derived from mutant mice expressed abundant Cx43 and higher levels of involucrin and loricrin under low calcium conditions. However, after calcium-induced differentiation, similar levels of Cx43, involucrin and loricrin were observed. Thus, we conclude that during wound healing, mutant Cx43 may enhance keratinocyte proliferation and promote early differentiation of keratinocytes.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22775996     DOI: 10.1111/j.1600-0625.2012.01532.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  10 in total

1.  A Multicenter Randomized Controlled Trial Evaluating a Cx43-Mimetic Peptide in Cutaneous Scarring.

Authors:  Christina L Grek; Jade Montgomery; Meenakshi Sharma; A Ravi; J S Rajkumar; Kurtis E Moyer; Robert G Gourdie; Gautam S Ghatnekar
Journal:  J Invest Dermatol       Date:  2016-11-14       Impact factor: 8.551

2.  Panx1 regulates cellular properties of keratinocytes and dermal fibroblasts in skin development and wound healing.

Authors:  Silvia Penuela; John J Kelly; Jared M Churko; Kevin J Barr; Amy C Berger; Dale W Laird
Journal:  J Invest Dermatol       Date:  2014-02-12       Impact factor: 8.551

3.  Connexin hemichannels influence genetically determined inflammatory and hyperproliferative skin diseases.

Authors:  Noah A Levit; Thomas W White
Journal:  Pharmacol Res       Date:  2015-07-23       Impact factor: 7.658

4.  Myogenic bladder defects in mouse models of human oculodentodigital dysplasia.

Authors:  Tao Huang; Qing Shao; Kevin Barr; Jamie Simek; Glenn I Fishman; Dale W Laird
Journal:  Biochem J       Date:  2014-02-01       Impact factor: 3.857

5.  Aberrant Cx43 Expression and Mislocalization in Metastatic Human Melanomas.

Authors:  Katanya C Alaga; Melissa Crawford; Lina Dagnino; Dale W Laird
Journal:  J Cancer       Date:  2017-04-09       Impact factor: 4.207

Review 6.  Connexin 43-Based Therapeutics for Dermal Wound Healing.

Authors:  Jade Montgomery; Gautam S Ghatnekar; Christina L Grek; Kurtis E Moyer; Robert G Gourdie
Journal:  Int J Mol Sci       Date:  2018-06-15       Impact factor: 5.923

7.  Comparative Analysis of Cx31 and Cx43 in Differentiation-Competent Rodent Keratinocytes.

Authors:  Akina Au; Qing Shao; Kyra K White; Sergiu A Lucaciu; Jessica L Esseltine; Kevin Barr; Dale W Laird
Journal:  Biomolecules       Date:  2020-10-14

8.  The connexin 43 carboxyl terminal mimetic peptide αCT1 prompts differentiation of a collagen scar matrix in humans resembling unwounded skin.

Authors:  Jade Montgomery; William J Richardson; Spencer Marsh; J Matthew Rhett; Francis Bustos; Katherine Degen; Gautam S Ghatnekar; Christina L Grek; L Jane Jourdan; Jeffrey W Holmes; Robert G Gourdie
Journal:  FASEB J       Date:  2021-08       Impact factor: 5.834

9.  The effect of a connexin43-based Peptide on the healing of chronic venous leg ulcers: a multicenter, randomized trial.

Authors:  Gautam S Ghatnekar; Christina L Grek; David G Armstrong; Sanjay C Desai; Robert G Gourdie
Journal:  J Invest Dermatol       Date:  2014-07-29       Impact factor: 8.551

10.  Disease-linked connexin26 S17F promotes volar skin abnormalities and mild wound healing defects in mice.

Authors:  Eric Press; Katanya C Alaga; Kevin Barr; Qing Shao; Felicitas Bosen; Klaus Willecke; Dale W Laird
Journal:  Cell Death Dis       Date:  2017-06-01       Impact factor: 8.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.